Lustgarten-funded science has been a driving force in every major development in pancreatic cancer since our founding in 1998.
As the world’s largest private funder of pancreatic cancer research, we aim to advance breakthroughs in the understanding of the initiation and progression of pancreatic cancer to improve the diagnosis and treatment of the disease – ultimately providing more hope for the future.
Lustgarten Foundation’s Guiding Research Principles:
- Support innovative research to fill knowledge gaps.
- Take large risks to drive new research opportunities and promising initiatives.
- Create and sustain partnerships with stakeholders and other funders that leverage resources and complement strengths to fill gaps and remove barriers.
- Cultivate collaboration to bring required expertise to the field and address specific challenges.
Our cutting-edge research portfolio includes: